JP Morgan Chase’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-385,738
| Closed | -$83.7M | – | 6826 |
|
|
2021
Q1 | $83.7M | Buy |
385,738
+382,962
| +13,795% | +$72M | 0.01% | 929 |
|
|
2020
Q4 | $321K | Sell |
2,776
-3,910
| -58% | -$438K | ﹤0.01% | 4617 |
|
|
2020
Q3 | $655K | Buy |
6,686
+767
| +13% | +$88.3K | ﹤0.01% | 3863 |
|
|
2020
Q2 | $727K | Buy |
5,919
+331
| +6% | +$37.6K | ﹤0.01% | 3684 |
|
|
2020
Q1 | $490K | Sell |
5,588
-866
| -13% | -$91.7K | ﹤0.01% | 3823 |
|
|
2019
Q4 | $675K | Buy |
6,454
+1,270
| +24% | +$142K | ﹤0.01% | 4087 |
|
|
2019
Q3 | $596K | Sell |
5,184
-4,743
| -48% | -$720K | ﹤0.01% | 4096 |
|
|
2019
Q2 | $1.69M | Buy |
9,927
+5,826
| +142% | +$1.01M | ﹤0.01% | 3492 |
|
|
2019
Q1 | $691K | Sell |
4,101
-2,270
| -36% | -$338K | ﹤0.01% | 4017 |
|
|
2018
Q4 | $620K | Buy |
6,371
+5,248
| +467% | +$689K | ﹤0.01% | 4022 |
|
|
2018
Q3 | $193K | Sell |
1,123
-21,623
| -95% | -$3.12M | ﹤0.01% | 4699 |
|
|
2018
Q2 | $3.17M | Buy |
22,746
+1,762
| +8% | +$250K | ﹤0.01% | 3043 |
|
|
2018
Q1 | $2.36M | Buy |
20,984
+20,512
| +4,346% | +$2.58M | ﹤0.01% | 3147 |
|
|
2017
Q4 | $62K | Sell |
472
-8,300
| -95% | -$975K | ﹤0.01% | 4828 |
|
|
2017
Q3 | $985K | Buy |
8,772
+8,171
| +1,360% | +$875K | ﹤0.01% | 3529 |
|
|
2017
Q2 | $61K | Sell |
601
-10,994
| -95% | -$1.18M | ﹤0.01% | 4312 |
|
|
2017
Q1 | $1.4M | Sell |
11,595
-8,742
| -43% | -$1.07M | ﹤0.01% | 3240 |
|
|
2016
Q4 | $2.27M | Buy |
20,337
+12,604
| +163% | +$1.52M | ﹤0.01% | 2980 |
|
|
2016
Q3 | $1.03M | Sell |
7,733
-64,051
| -89% | -$6.12M | ﹤0.01% | 3122 |
|
|
2016
Q2 | $6.57M | Sell |
71,784
-32,262
| -31% | -$2.72M | ﹤0.01% | 2110 |
|
|
2016
Q1 | $7.51M | Buy |
104,046
+26,405
| +34% | +$1.45M | ﹤0.01% | 1959 |
|
|
2015
Q4 | $5.39M | Buy |
77,641
+8,054
| +12% | +$656K | ﹤0.01% | 2182 |
|
|
2015
Q3 | $6.36M | Buy |
69,587
+15,463
| +29% | +$1.72M | ﹤0.01% | 2071 |
|
|
2015
Q2 | $6.65M | Buy |
54,124
+25,117
| +87% | +$2.85M | ﹤0.01% | 2214 |
|
|
2015
Q1 | $2.64M | Buy |
29,007
+21,925
| +310% | +$1.78M | ﹤0.01% | 2741 |
|
|
2014
Q4 | $480K | Buy |
+7,082
| New | +$517K | ﹤0.01% | 3688 |
|
Other funds holding GWPH
JP Morgan Chase's GWPH Position: Q2 2021 in Review
JP Morgan Chase sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 385,738 shares — an estimated $83.7M sold.
JP Morgan Chase first reported a position in GWPH in Q4 2014 and held it in 26 quarters. The position peaked at $83.7M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.
- JP Morgan Chase reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
- JP Morgan Chase sold 385,738 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $83.7M.
- JP Morgan Chase first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2014 and held it in 26 quarters.
- JP Morgan Chase's GW Pharmaceuticals Plc American Depositary Shares position peaked at $83.7M in Q1 2021.
- 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.
Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.